| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |